×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACRV – acrivon therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACRV
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/19
07:21 am
acrv
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Medium
Report
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
3/17
06:16 pm
acrv
Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors [Yahoo! Finance]
Low
Report
Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors [Yahoo! Finance]
3/17
05:54 pm
acrv
Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors
Low
Report
Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors
3/3
01:47 pm
acrv
Acrivon Therapeutics, Inc. (ACRV) Upgraded to Buy: Here's Why [Yahoo! Finance]
Medium
Report
Acrivon Therapeutics, Inc. (ACRV) Upgraded to Buy: Here's Why [Yahoo! Finance]
3/2
09:02 pm
acrv
Acrivon Therapeutics (ACRV) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
High
Report
Acrivon Therapeutics (ACRV) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/1
01:10 am
acrv
Acrivon Therapeutics (ACRV) was downgraded by Wall Street Zen from "h
Low
Report
Acrivon Therapeutics (ACRV) was downgraded by Wall Street Zen from "h
2/27
12:00 pm
acrv
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer [Yahoo! Finance]
Medium
Report
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer [Yahoo! Finance]
2/24
08:33 am
acrv
Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
07:42 am
acrv
Form S-8 Acrivon Therapeutics,
Medium
Report
Form S-8 Acrivon Therapeutics,
3/19
07:22 am
acrv
Form 8-K Acrivon Therapeutics, For: Mar 19
Medium
Report
Form 8-K Acrivon Therapeutics, For: Mar 19
3/19
07:11 am
acrv
Form 10-K Acrivon Therapeutics, For: Dec 31
Medium
Report
Form 10-K Acrivon Therapeutics, For: Dec 31
3/3
04:26 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Peterson Katharine
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Peterson Katharine
3/3
04:23 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Levy Adam D.
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Levy Adam D.
3/3
04:23 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Miller Mary
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Miller Mary
3/3
04:23 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Mirza Mansoor Raza
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Mirza Mansoor Raza
3/3
04:21 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Devroe Eric
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Devroe Eric
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: